Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 56.14%
August 31, 2026 56.14%
July 31, 2026 56.14%
June 30, 2026 56.14%
May 31, 2026 56.14%
April 30, 2026 56.14%
March 31, 2026 56.14%
February 28, 2026 56.14%
January 31, 2026 56.14%
December 31, 2025 56.14%
November 30, 2025 56.14%
October 31, 2025 56.14%
September 30, 2025 48.72%
August 31, 2025 48.72%
July 31, 2025 48.72%
June 30, 2025 48.72%
May 31, 2025 48.72%
April 30, 2025 48.72%
March 31, 2025 48.72%
February 28, 2025 52.29%
January 31, 2025 52.29%
December 31, 2024 52.29%
November 30, 2024 52.29%
October 31, 2024 52.29%
September 30, 2024 52.29%
Date Value
August 31, 2024 52.29%
July 31, 2024 52.29%
June 30, 2024 52.29%
May 31, 2024 52.29%
April 30, 2024 52.29%
March 31, 2024 52.29%
February 29, 2024 52.29%
January 31, 2024 52.29%
December 31, 2023 52.29%
November 30, 2023 52.29%
October 31, 2023 52.29%
September 30, 2023 52.29%
August 31, 2023 52.29%
July 31, 2023 52.29%
June 30, 2023 52.29%
May 31, 2023 52.29%
April 30, 2023 52.29%
March 31, 2023 52.29%
February 28, 2023 52.29%
January 31, 2023 52.29%
December 31, 2022 52.29%
November 30, 2022 52.29%
October 31, 2022 52.29%
September 30, 2022 52.29%
August 31, 2022 52.29%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lantheus Holdings, Inc. 59.46%
Globus Medical, Inc. 47.91%
Neogen Corp. 90.92%
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%